Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000293
Filing Date
2025-07-30
Accepted
2025-07-30 09:29:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4160
  Complete submission text file 0001964306-25-000293.txt   5638
Mailing Address C/O MIRAGEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD, #100 BOULDER CO 80301
Business Address
Levy Adam Scott (Reporting) CIK: 0001693134 (see all company filings)

Type: 144

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41614 | Film No.: 251164369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)